MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Amorphous & Spherical Nano Particles

PharmaNova Inc
Amorphous & Spherical Particles enhance your Compound

Full description

PharmaNova is pleased to inform you that two of the pioneers of Nanoparticle technology are available to collaborate with your company.  Dr. Michael Violante and Dr. Deepak Thassu are key Executives at our company, responsible for making your project successful, right from the start.

I will like to send to you non-confidential information, with your permission.

Please reply with your request for the documents to tom.biviano@pharmanovaco.com.

They will explain our technology and approach, and help you determine if we have synergy.

We may create synergy (or synergies for that matter) to work together if you can answer ‘yes’ to the following questions.

1: Are you looking for low cost product/formulation development?


2. Do you have poorly water soluble compounds and you need to increase bioavailability?


3. Will your business benefit from repurposing your APIs?


4. Will your API be improved and safer and less toxic with reduced excipient?


5. Are you looking for a way to develop a drug and tissue targeting approach for your APIs?


Our clients have this to say about us…
… very good to work with

… time is critical to my company… and (they) have responded very quickly

… I have an excellent relationship with PharmaNova and would not hesitate to recommend PharmaNova to others


We will have a non-confidential discussion to determine how your issues can be solved. Please respond to:
Tom.biviano@pharmanovaco.com or call 585-413-4721 x102

 

Development status

Preclinical

Type of business relationship sought

PharmaNova will provide services to quickly evaluate your compound.

We will do formulation testing and full reporting.

We then can do Optimization studies with full reporting.

Scale-up can then be performed.

Partnering is then accomplished to benefit both parties.

Licensing contact

Rodney Brown
President

Contact directly

Company details

PharmaNova Inc

PharmaNova Inc. is a specialty pharma company that develops & partners new products e.g. modified-release gabapentin for menopausal hot flushes (end Phase 3, 2009) and novel nanoparticulate medicines.

View profile

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us